Found: 5
Select item for more details and to access through your institution.
Inhibition of BRAF Sensitizes Thyroid Carcinoma to Immunotherapy by Enhancing tsMHCII-mediated Immune Recognition.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 12, p. 3970, doi. 10.7150/ijbs.81895
- By:
- Publication type:
- Article
Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 2, p. 1, doi. 10.1038/s41419-022-04550-0
- By:
- Publication type:
- Article
Preoperative supplementation of calcitriol and calcium relieves symptom and extent of hypocalcemia in patients undergoing total thyroidectomy and bilateral central compartment neck dissection: A prospective, randomized, open-label, parallel-controlled clinical study
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.967451
- By:
- Publication type:
- Article
Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 9, p. 1592, doi. 10.7150/jca.83853
- By:
- Publication type:
- Article